In vitro investigation of poor cerebrospinal fluid suppression on fluid-attenuated inversion recovery images in the presence of a gadolinium-based contrast agent

Magnetic Resonance in Medicine

Volumn 60, Issue 1, 2008, Pages 220-223

  Bonzano, Laura ^a,d   Roccatagliata, L ^a   Levrero, F ^b   Mancardi, G L ^a   Sardanelli, F ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d Departments of Neurosciences Ophthalmology and Genetics   (Italy)

Author keywords

Cerebrospinal fluid; Fluid attenuated inversion recovery (FLAIR); Fluid attenuated inversion recovery images; Gadolinium chelate blood brain barrier; T1 T2 relaxation

Indexed keywords

BLOOD; BRAIN; GADOLINIUM; GADOLINIUM COMPOUNDS; IMAGE ENHANCEMENT; RECOVERY;

BLOOD-BRAIN BARRIER; CEREBRO SPINAL FLUIDS; CONTRAST AGENT; FLUID ATTENUATED INVERSION RECOVERIES; MULTIPLE SCLEROSIS; SIGNAL INTENSITIES; T1 RELAXATION; T2 RELAXATION;

CEREBROSPINAL FLUID;

GADOLINIUM PENTETATE;

ARTICLE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID; CONCENTRATION RESPONSE; CONTRAST ENHANCEMENT; IMAGE PROCESSING; IN VITRO STUDY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; SIGNAL PROCESSING; STROKE;

EID: 46849119841     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.21619     Document Type: Article

References (12)

1. Latour LL, Kang DW, Ezzeddine MA, Chalela JA, Warach S. Early blood-brain barrier disruption in human focal brain ischemia. Ann Neurol 2004;56:468-477.
2. Bozzao A, Floris R, Fasoli F, Fantozzi LM, Colonnese C, Simonetti G. Cerebrospinal fluid changes after intravenous injection of gadolinium chelate: assessment by FLAIR MR imaging. Eur Radiol 2003;13:592-597.
3. Mathews VP, Caldemeyer KS, Lowe MJ, Greenspan SL, Weber DM, Ulmer JL. Brain: gadolinium-enhanced fast fluid-attenuated inversion-recovery MR imaging. Radiology 1999;211:257-263.
4. Rennels ML, Blaumanis OR, Grady PA. Rapid solute transport throughout the brain via paravascular fluid pathways. Adv Neurol 1990;52:431-439.
5. Rennels ML, Gregory TF, Blaumanis OR, Fujimoto K, Grady PA. Evidence for a 'paravascular' fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space. Brain Res 1985;326:47-63.
6. Lunardi G, Parodi A, Perasso L, Pohvozcheva AV, Scarrone S, Adriano E, Florio T, Gandolfo C, Cupello A, Burov SV, Balestrino M. The creatine transporter mediates the uptake of creatine by brain tissue, but not the uptake of two creatine-derived compounds. Neuroscience 2006;142:991-997.
7. Abramoff MD, Magelhaes PJ, Ram SJ. Image Processing with ImageJ. Biophotonics Int 2004;11:36-42.
8. Morkenborg J, Pedersen M, Jensen FT, Stodkilde-Jorgensen H, Djurhuus JC, Frokiaer J. Quantitative assessment of Gd-DTPA contrast agent from signal enhancement: an in-vitro study. Magn Reson Imaging 2003;21:637-643.
9. Galassi W, Phuttharak W, Hesselink JR, Healy JF, Dietrich RB, Imbesi SG. Intracranial meningeal disease: comparison of contrast-enhanced MR imaging with fluid-attenuated inversion recovery and fat-suppressed T1-weighted sequences. AJNR Am J Neuroradiol 2005;26:553-559.
10. Mamourian AC, Hoopes PJ, Lewis LD. Visualization of intravenously administered contrast material in the CSF on fluid-attenuated inversion-recovery MR images: an in vitro and animal-model investigation. AJNR Am J Neuroradiol 2000;21:105-111.
11. Mitchell DG. MRI principles. Philadelphia: W. B. Saunders; 1999.
12. Hochmeister S, Grundtner R, Bauer J, Engelhardt B, Lyck R, Gordon G, Korosec T, Kutzelnigg A, Berger JJ, Bradl M, Bittner RE, Lassmann H. Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis. J Neuropathol Exp Neurol 2006;65:855-865.